当前位置:首页 - 行情中心 - 小方制药(603207) - 财务分析 - 现金流量表

小方制药

(603207)

  

流通市值:14.28亿  总市值:42.22亿
流通股本:5440.00万   总股本:1.61亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金152,687,702.87562,228,319.24416,771,775.69256,905,594.88
  收到的税费返还-2,237,093.2185,619.7431,390.17
  收到其他与经营活动有关的现金2,134,423.831,575,392.682,397,923.32877,240.84
  经营活动现金流入小计154,822,126.7566,040,805.13419,255,318.75257,814,225.89
  购买商品、接受劳务支付的现金59,176,695.59191,833,932.62143,013,356.6973,184,112.76
  支付给职工以及为职工支付的现金22,350,597.7880,796,240.246,896,555.8333,799,742.52
  支付的各项税费18,885,091.9988,358,064.7165,190,948.9742,362,996.17
  支付其他与经营活动有关的现金9,078,514.7444,255,918.1230,217,739.4618,208,287.74
  经营活动现金流出小计109,490,900.1405,244,155.65285,318,600.95167,555,139.19
  经营活动产生的现金流量净额45,331,226.6160,796,649.48133,936,717.890,259,086.7
二、投资活动产生的现金流量:
  收回投资收到的现金3,000,000923,000,000553,000,000453,000,000
  取得投资收益收到的现金1,730,208.334,138,663.883,660,316.663,370,913.89
  处置固定资产、无形资产和其他长期资产收回的现金净额-110,619.47110,619.47-
  投资活动现金流入小计4,730,208.33927,249,283.35556,770,936.13456,370,913.89
  购建固定资产、无形资产和其他长期资产支付的现金56,097,176.7854,240,215.6449,140,746.7530,958,225.01
  投资支付的现金303,000,000567,000,000420,000,000420,000,000
  投资活动现金流出小计359,097,176.78621,240,215.64469,140,746.75450,958,225.01
  投资活动产生的现金流量净额-354,366,968.45306,009,067.7187,630,189.385,412,688.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,320,621.418,382,705.998,382,705.998,382,705.99
  收到其他与筹资活动有关的现金6,354,357.21,119,069.581,776,039.74652,392.2
  筹资活动现金流入小计9,674,978.619,501,775.5710,158,745.739,035,098.19
  分配股利、利润或偿付利息支付的现金-353,231,927.4240,839,950.5240,839,950.5
  支付其他与筹资活动有关的现金40,5005,735,8205,170,0005,170,000
  筹资活动现金流出小计40,500358,967,747.4246,009,950.5246,009,950.5
  筹资活动产生的现金流量净额9,634,478.61-349,465,971.83-235,851,204.77-236,974,852.31
五、现金及现金等价物净增加额-299,401,263.24117,339,745.36-14,284,297.59-141,303,076.73
  加:期初现金及现金等价物余额544,189,596.35426,849,850.99426,849,850.99426,849,850.99
  期末现金及现金等价物余额244,788,333.11544,189,596.35412,565,553.4285,546,774.26
补充资料:
  净利润-207,489,677.18-120,821,251.32
  资产减值准备-183,048.19--2,202.53
  固定资产和投资性房地产折旧-1,928,961.94-846,598.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,928,961.94-846,598.19
  无形资产摊销-9,350.76-4,675.38
  长期待摊费用摊销-99,144.12-120,333.42
  递延收益摊销--12,857.16--6,428.58
  处置固定资产、无形资产和其他长期资产的损失--110,619.47--
  财务费用--532,028.58--1,828,644.31
  递延所得税--1,321,536.72-1,255,646.57
  其中:递延所得税资产减少--1,321,536.72-1,255,646.57
  存货的减少--24,161,113.86-2,400,680.55
  经营性应收项目的减少--48,716,490.55--29,828,024.36
  经营性应付项目的增加-20,425,168.79--6,517,426.07
  现金的期末余额-544,189,596.35-285,546,774.26
  减:现金的期初余额-426,849,850.99-426,849,850.99
  现金及现金等价物的净增加额-117,339,745.36--141,303,076.73
公告日期2026-04-282026-04-282025-10-252025-08-26
审计意见(境内)标准无保留意见
TOP↑